Last reviewed · How we verify
Darunavir and Cobicistat
Darunavir and Cobicistat is a Small molecule drug developed by Shanghai Public Health Clinical Center. It is currently FDA-approved.
At a glance
| Generic name | Darunavir and Cobicistat |
|---|---|
| Sponsor | Shanghai Public Health Clinical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV (PHASE2, PHASE3)
- A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments (PHASE4)
- Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy (PHASE3)
- The Late Presenter Treatment Optimisation Study (PHASE3)
- Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
- Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 (PHASE3)
- Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum
- Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Darunavir and Cobicistat CI brief — competitive landscape report
- Darunavir and Cobicistat updates RSS · CI watch RSS
- Shanghai Public Health Clinical Center portfolio CI
Frequently asked questions about Darunavir and Cobicistat
What is Darunavir and Cobicistat?
Darunavir and Cobicistat is a Small molecule drug developed by Shanghai Public Health Clinical Center.
Who makes Darunavir and Cobicistat?
Darunavir and Cobicistat is developed and marketed by Shanghai Public Health Clinical Center (see full Shanghai Public Health Clinical Center pipeline at /company/shanghai-public-health-clinical-center).
What development phase is Darunavir and Cobicistat in?
Darunavir and Cobicistat is FDA-approved (marketed).